Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VACC-UP: Intrahospital Influenza Vaccination in Patients at High Cardiovascular Risk
NCT07721649Recruiting
- Start
- Sep 2026
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
Randomised, open-label trial of ARCT-2138 in influenza (2 arms). Primary endpoint: Influenza vaccination rate at the end of the index influenza season at 7 months. Started Sep 2026; status: recruiting.
02
Drugs
ARCT-2138
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07721649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07721649.